Please login to the form below

Not currently logged in
Email:
Password:

Intercept Pharmaceuticals

This page shows the latest Intercept Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

Intercept gets EU nod for rare liver disease therapy

Intercept gets EU nod for rare liver disease therapy

Ocaliva approved as a combination treatment for primary biliary cholangitis. Intercept Pharma now has approval for its Ocaliva drug for primary biliary cholangitis (PBC) therapy Ocaliva on both sides of the ... Intercept launched Ocaliva in the US

Latest news

  • Gilead chalks up trial success for new NASH drug Gilead chalks up trial success for new NASH drug

    The company is vying with rivals such as Allergan and Intercept Pharmaceuticals in its pursuit of the NASH market. . ... Allergan has been building a pipeline of candidates through a series of bolt-on acquisitions including Akarna Therapeutics and

  • Takeda enlists GE's aid to tackle liver fibrosis epidemic Takeda enlists GE's aid to tackle liver fibrosis epidemic

    Takeda is playing catch-up in the liver fibrosis race, with rivals such as Gilead Sciences, Intercept Pharmaceuticals, Galectin Therapeutics and Genfit already having compounds in the clinic. ... Gilead's simtuzumab is in phase II testing in NASH, while

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Simon Doyle joins STEM Simon Doyle joins STEM

    Doyle - who joins the group from Intercept Pharmaceuticals where he was executive director of commercial operations and marketing - will be at the forefront of a number of key accounts to help

  • Glenn Sblendorio to retire as president of The Medicines Company Glenn Sblendorio to retire as president of The Medicines Company

    He has over 20 years of experience in the pharmaceutical industry and prior to joining The Medicines Company held senior managing and financial positions at Eyetech Pharmaceuticals and MPM Capital Advisors. ... He currently serves as a director at Amicus

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

The new UK government-pharma industry pricing agreement – welcome news, but there are lessons to be learnt
...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again – in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics